Which assessment tool is utilized to evaluate tardive dyskinesia?

The Abnormal Involuntary Movement Scale (AIMS) is specifically designed to assess and quantify the severity of tardive dyskinesia. This condition is characterized by involuntary, repetitive movements, often associated with the long-term use of antipsychotic medications. AIMS involves a structured clinical evaluation where the clinician observes the patient for abnormal movements in the facial area, limbs, and trunk, and scores them accordingly. The scale is essential in both diagnosing tardive dyskinesia and monitoring its progression or improvement over time after treatment changes.

In contrast, the other assessment tools mentioned are focused on different aspects of movement disorders. The Bradley scale, for instance, is used to assess various involuntary movements but is not specific to tardive dyskinesia. The Movement Disorder Society Scale evaluates different types of movement disorders but is not tailored specifically to the assessment of tardive dyskinesia. Lastly, the Simpson-Angus Scale assesses extrapyramidal symptoms related to antipsychotic use but does not specifically quantify tardive dyskinesia movements. Each of these tools serves a unique purpose, but the AIMS is the standardized tool for evaluating tardive dyskinesia.